| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8226817 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 9 Pages |
Abstract
Overall survival, NS, and RS are improved in patients with HER2+ tumors, relative to those with HER2â lesions, and HER2 amplification is independently associated with increased survival in patients with BM from breast cancer. Our findings suggest that the prognosis of HER2+ patients may be better than that of otherwise similar patients who are HER2â and that stereotactic radiosurgery may be beneficial for some patients with HER2+ lesions.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Zhiyuan M.D., Nicholas F. M.D., Sam T. M.D., Lilyana M.D., Michael A. M.D., Ph.D., John H. M.D., Gene H. M.D., Robert J. M.D.,